As of 22 Sept 2026, Amrutanjan Health Care Ltd share price is ₹501.00. The stock opened at ₹501.00 and had closed at ₹495.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹476.85 and a high of ₹772.10. In terms of performance, Amrutanjan Health Care Ltd share price has decreased by 4.38% over the past six months and has decreased by 34.44% over the last year.
AMRUTANJAN Stock Price Chart
Amrutanjan Health Care Ltd Overview
About AMRUTANJAN
Amrutanjan Health Care is engaged in the business of manufacture, supply, sale of products in pain management, congestion management, beverages and Women's Hygiene & Personal Care and services in pain management.
Amrutanjan Health Care Ltd Historical Performance
Amrutanjan Health Care Ltd Fundamentals
Amrutanjan Health Care Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 520.12 | 469.50 | 437.58 | 394.18 | 421.22 |
| EBITDA | 84.41 | 75.88 | 68.17 | 58.94 | 94.86 |
| Net Profit | 57.92 | 50.83 | 44.97 | 39.83 | 67.19 |
| EPS | 20.03 | 17.58 | 15.50 | 13.65 | 23.05 |
Amrutanjan Health Care Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 492.07 |
| Resistance 1 (R1) | 497.67 |
| Pivot Point | 494.28 |
Amrutanjan Health Care Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 11-Sep-2026 | 08-May-2026 | 11-Sep-2026 | Final | ₹2.90 |
| 06-Feb-2026 | 03-Feb-2026 | 07-Feb-2026 | Interim 2 | ₹1.00 |
| 18-Nov-2025 | 10-Nov-2025 | 18-Nov-2025 | Interim 1 | ₹1.00 |
| 16-Sep-2025 | 15-May-2025 | 16-Sep-2025 | Final | ₹2.60 |
| 18-Feb-2025 | 12-Feb-2025 | 18-Feb-2025 | Interim 2 | ₹1.00 |
AMRUTANJAN Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| S Sambhuprasad | Chairman |
| Ramaa Prabhakar Arikirevula | Non Executive Independent Director |
| G Raghavan | Non Executive Independent Director |
Amrutanjan Health Care Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,863.20-0.30% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,401.00-0.10% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,956.50-0.27% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Amrutanjan Health Care Ltd today is ₹501.00 on NSE and ₹501.00 on BSE.
- The 52-week high of Amrutanjan Health Care Ltd is ₹772.10, while the 52-week low is ₹476.85.
- The current market capitalisation of Amrutanjan Health Care Ltd is approximately ₹1,432 crore.
- The P/E (Price-to-Earnings) ratio of Amrutanjan Health Care Ltd is 26.54. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Amrutanjan Health Care Ltd is 3.87. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Amrutanjan Health Care Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AMRUTANJAN on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Amrutanjan Health Care Ltd has delivered a return of approximately -21.80%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Amrutanjan Health Care Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 46.52% promoters, -3.38% FIIs, 12.28% DIIs, and 32.06% public shareholders.

